Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Bioanalytical Syst (BASI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 23,072
  • Shares Outstanding, K 8,240
  • Annual Sales, $ 20,440 K
  • Annual Income, $ -3,230 K
  • 36-Month Beta 1.36
  • Price/Sales 1.02
  • Price/Cash Flow N/A
  • Price/Book 3.20

Price Performance

See More
Period Period Low Period High Performance
1-Month
2.03 +37.44%
on 11/15/17
2.95 -5.42%
on 12/11/17
+0.74 (+36.10%)
since 11/14/17
3-Month
1.61 +73.29%
on 09/19/17
2.95 -5.42%
on 12/11/17
+1.17 (+72.22%)
since 09/14/17
52-Week
0.65 +329.23%
on 01/10/17
2.95 -5.42%
on 12/11/17
+1.95 (+232.14%)
since 12/14/16

Most Recent Stories

More News
BASi Announces Enhanced Bioequivalence Capabilities

WEST LAFAYETTE, IN / ACCESSWIRE / December 12, 2017 / Bioanalytical Systems Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced a multi-tiered strategy aimed at enhancing the company's in vitro...

BASI : 2.79 (-0.36%)
Steady Growth Spurs Plans for BASi Expansion of GLP Toxicology Facility in Indiana

Investment Adds New Capabilities and State-of-the-Art Responsible Care Environment

BASI : 2.79 (-0.36%)
Gaining Momentum: BASi Adds Candace Rohde-Johnson as Director of in Vivo Products and Services

WEST LAFAYETTE, IN / ACCESSWIRE / October 3, 2017 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company")today announced the addition of Candace Rohde-Johnson as Director of In Vivo Products...

BASI : 2.79 (-0.36%)
BASi Strengthens Preclinical PK/PD Leadership With the Hiring of James E. Burleigh as Director of Operations, Preclinical PK/PD

WEST LAFAYETTE, IN / ACCESSWIRE / September 19, 2017 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced the addition of James E. Burleigh as Director of Operations,...

BASI : 2.79 (-0.36%)
BASi and JOANNEUM RESEARCH Enter Into Collaboration to Commercialize Open Flow Microperfusion Technology

WEST LAFAYETTE, IN / ACCESSWIRE / September 6, 2017 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company"), a recognized global leader in the development of instrumentation for microdialysis...

BASI : 2.79 (-0.36%)
BASi Announces New Universal Caging System for Automated Sampling With Focus on Researcher-Friendly Design

WEST LAFAYETTE, IN / ACCESSWIRE / August 28, 2017 / Bioanalytical Systems, Inc. (NASDAQ: BASI) (" BASi" or the "Company") today announced the launch of its Universal Caging System that is compatible with...

BASI : 2.79 (-0.36%)
BASi Completes Refinancing of Senior Secured Credit Facilities

WEST LAFAYETTE, IN / ACCESSWIRE / June 27, 2017 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced that it has successfully completed the refinancing of its existing...

BASI : 2.79 (-0.36%)
BASi Names Dr. Gregory C. Davis to Board of Directors

WEST LAFAYETTE, IN / ACCESSWIRE / June 20, 2017 / Bioanalytical Systems, Inc. (NASDAQ: BASI) ("BASi" or the "Company") today announced that the board of directors unanimously elected Dr. Gregory C. Davis...

BASI : 2.79 (-0.36%)
BASi Reports Second Quarter Results

Bioanalytical Systems, Inc. (NASDAQ:BASI) ("BASi" or the "Company") today announced financial results for the second quarter and first six months of fiscal 2017.

BASI : 2.79 (-0.36%)
BASi Names Philip A. Downing Senior Vice President of Preclinical Services

Bioanalytical Systems, Inc. (NASDAQ:BASI) ("BASi" or the "Company") today announced that Philip A. Downing has been promoted to Senior Vice President, Preclinical Services.

BASI : 2.79 (-0.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Maximum. Long term indicators fully support a continuation of the trend.

See More

Business Summary

Bioanalytical Systems, Inc. is a contract research organization providing research and development resources to many of the leading pharmaceutical, medical device and biotechnology companies in the world. The company offers an efficient, variable-cost alternative to its clients' internal product...

See More

Key Turning Points

2nd Resistance Point 2.88
1st Resistance Point 2.83
Last Price 2.79
1st Support Level 2.76
2nd Support Level 2.74

See More

52-Week High 2.95
Last Price 2.79
Fibonacci 61.8% 2.07
Fibonacci 50% 1.80
Fibonacci 38.2% 1.53
52-Week Low 0.65

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.